Compare Prudential Financial Inc (PRU) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prudential Financial Inc vs Zoetis Inc — how do they compare? Prudential Financial Inc trades at $113.09 (market cap $39.17B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Prudential Financial Inc is the larger of the two by market cap, and Prudential Financial Inc pays the higher dividend (4.93%). Which is the better fit depends on your goals — on Pluang, investors hold Prudential Financial Inc for 145 Days and Zoetis Inc for 70 Days on average.
| PRU | ZTS | |
|---|---|---|
Market Cap | $39.17B | $30.20B |
Volume | 1,436,917 | 6,175,327 |
Sector | Financials | Health |
52-Week High | $125.13 | $147.53 |
52-Week Low | $92.00 | $69.09 |
Typical Hold Time | 145 Days | 70 Days |
Enterprise Value | $67.95B | $37.76B |
Dividend Yield | 4.93% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Prudential Financial (PRU) trades at $113.53, up 1.04% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates solid fundamentals with a P/E of 10.29 and ROE of 12.46%, while recent earnings show two consecutive beats. Strategic moves include the Alexforbes stake sale and rebranding to Prudential Wealth Advisors, reflecting focus on core operations.
PRU presents a value opportunity with attractive valuation metrics, though analyst consensus is cautious with 67.57% hold ratings. Key risks include interest rate sensitivity and execution of the $3B capital rotation plan. The stock trades above the $105.67 consensus target, suggesting limited near-term upside despite strong annuity market positioning.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
